RECURRENT BLADDER CARCINOMA
Clinical trials for RECURRENT BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for rare bladder cancer mutation
Disease control OngoingThis study tests a drug called sapanisertib in people with advanced bladder cancer that has a specific change in the TSC1 or TSC2 gene. The drug works by blocking a protein that helps cancer cells grow. The goal is to see if the drug can shrink tumors and how well people tolerate…
Matched conditions: RECURRENT BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes in a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced or hard-to-treat cancers (solid tumors, lymphoma, or myeloma) had their tumors genetically screened. Those with specific genetic c…
Matched conditions: RECURRENT BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC